Novartis confirms ‘thousands’ of layoffs loom as its global reorganization rolls aheadnews2022-04-26T20:20:47+00:00April 26th, 2022|Fierce Pharma|
After Biohaven stopped teasing Nurtec’s quarterly performance, should investors be worried?news2022-04-26T16:36:21+00:00April 26th, 2022|Fierce Pharma|
Novartis CEO: Leqvio, Pluvicto off to solid starts, but blockbuster sales will take timenews2022-04-26T15:20:28+00:00April 26th, 2022|Fierce Pharma|
Lawmakers ask FDA to lay out plans for reviewing COVID vaccines for young childrennews2022-04-26T15:04:04+00:00April 26th, 2022|Fierce Pharma|
Genentech makes strides toward 2025 D&I goal that spans research, in-house staffing and suppliersnews2022-04-26T14:55:22+00:00April 26th, 2022|Fierce Pharma|
Sanofi offloads rights to prolonged-release antipsychotic drugnews2022-04-26T14:06:51+00:00April 26th, 2022|Fierce Pharma|
Sol-Gel gets FDA approval for encapsulated skin disease drugnews2022-04-26T14:03:31+00:00April 26th, 2022|Fierce Pharma|
US to increase availability of Pfizer’s Paxlovid even as demand remains spottynews2022-04-26T13:17:52+00:00April 26th, 2022|Fierce Pharma|
Sanofi taps McLaren to apply racing know-how to pharma manufacturingnews2022-04-26T12:57:44+00:00April 26th, 2022|Fierce Pharma|
Amcor to add more capabilities at packaging site in Irelandnews2022-04-26T12:40:38+00:00April 26th, 2022|Fierce Pharma|
